Ronelle Moodliar

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

Andrew Nunn, Patrick Phillips, Sarah Meredith et al. · New England Journal of Medicine · 2019 · 402 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · New England Journal of Medicine · 2022 · 352 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 145 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +11

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · The Lancet Respiratory Medicine · 2023 · 96 citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +12

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB

Conor Tweed, Genevieve H. Wills, Angela M. Crook et al. · The International Journal of Tuberculosis and Lung Disease · 2021 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10